Carriers of E40K mutation (ANGPTL4 inactive variant) in addition to lower plasma TG, have also less risk of developing T2D54,61–63, and are more protected against metabolic alterations associated with obesity than noncarriers64. Here, ANGPTL4 is linked to obesity disorder.